Galera Labs, LLC;Board of Regents of the University of Texas System
发明人:
KEENE, Jeffery L.,RILEY, Dennis P.,BEARDSLEY, Robert A.,STORY, Michael Dean,MAPUSKAR, Kranti Ashok,SPITZ, Jr., Douglas R.,ALLEN, Bryan G.,DAVIS, Andrew Blake,ZEPEDA OROZCO, Diana
申请号：
AU2019215032
公开号：
AU2019215032A1
申请日:
2019.01.31
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
A method of treating a cancer in a mammalian subject afflicted with the cancer, consisting essentially of administering to the subject a therapeutically effective amount of a platinum-based anticancer agent, and administering to the subject a therapeutically effective amount of a pentaaza macrocyclic ring complex corresponding to the Formula (I) below, prior to, concomitantly with, or after administration of the platinum-based anticancer agent, whereby response of the cancer to the platinum-based anticancer agent is increased.
